info@contemporaryhealth.co.uk

+44 (0)20 3773 4895

logologologo
  • Home
  • The College
    • Mission & Approach
    • Advisory Board
    • Our Faculty and Staff
  • Our Courses
    • CPD Short Courses
    • Postgraduate Qualifications
      • Postgraduate Certificate
      • Postgraduate Diploma
      • MSc
    • Testimonials
  • Free Resources
    • Free Toolkits
    • News
    • Jobs in the Obesity Field
    • Prospectus Download
  • Apply
    • Apply
    • Funding options
  • Contact Us
  • Student Login

No products in the cart.

logologologo
  • Home
  • The College
    • Mission & Approach
    • Advisory Board
    • Our Faculty and Staff
  • Our Courses
    • CPD Short Courses
    • Postgraduate Qualifications
      • Postgraduate Certificate
      • Postgraduate Diploma
      • MSc
    • Testimonials
  • Free Resources
    • Free Toolkits
    • News
    • Jobs in the Obesity Field
    • Prospectus Download
  • Apply
    • Apply
    • Funding options
  • Contact Us
  • Student Login

No products in the cart.

  • Home
  • The College
    • Mission & Approach
    • Advisory Board
    • Our Faculty and Staff
  • Our Courses
    • CPD Short Courses
    • Postgraduate Qualifications
      • Postgraduate Certificate
      • Postgraduate Diploma
      • MSc
    • Testimonials
  • Free Resources
    • Free Toolkits
    • News
    • Jobs in the Obesity Field
    • Prospectus Download
  • Apply
    • Apply
    • Funding options
  • Contact Us
  • Student Login
August 2, 2017 by Nicholas Feenie Obesity News Bulletin 0 comments

New combination of drugs cause enhanced weight loss

Researchers at the University of Pennsylvania have found that a unique combination of weight loss drugs can have a dramatic effect on laboratory animals. The researchers studied the effect of two different drug classes that affect the hormones amylin and glucagon-like peptide-1 (GLP-1). They found that cycling between the two drug regimens over the course of a month achieved a greater degree of weight loss than normal regimens. These include a continuous combined therapy or using just one of the drugs.

Unlike many other trials that examine new drugs, this research involves drugs that are already approved by many different organisations, including the FDA. This means that the types of regimens being suggested could be in use in the very near future. Currently, the authors are finalising their work to show how the two hormonal systems interact with each other to achieve this greater weight loss.

PREV
NEXT

Related Posts

November 23, 2016
Does brain volume predict successfulness at weight loss?
Read More
November 9, 2016
Weight discrimination doubles health risk
Read More
November 16, 2017
Obese older adults that have undergone cardiac surgery at higher risk of poor functioning
Read More
June 27, 2017
Global research project reveals 30% of the world’s population affected by weight problems
Read More

CCH LINKS

FAQ
HOW TO APPLY
ACADEMIC ADVISORY BOARD
FACULTY AND STAFF
TERMS & CONDITIONS
CCH EDUCATION SERVICES

OUR PARTNERS

NOF
Haringey Obesity Alliance
Skills Active
CPD UK
ASO
REPS
REPS SA
ACE

ABOUT CCH

CONTACT US
info@contemporaryhealth.co.uk
+44 (0)20 3773 4895
Technopark, 90 London Road, LONDON, SE1 6LN
 

© The College of Contemporary Health Ltd